In order to evaluate the potential regulatory molecular action of mechanisms that inhibiting chondrosarcoma cell survival and proliferation after CDK4 targeting treatment, the effect of palbociclib on progress of the cell cycle and apoptosis was examined. Here, CDK4 is linked to chondrosarcoma.